Low dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage. - Wikidata - awgldk - TriplyDB

Low dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage.

Low dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage.

http://www.wikidata.org/entity/Q37479967

about

Lack of Thromboxane Synthase Prevents Hypertension and Fetal Growth Restriction after High Salt Treatment during Pregnancy The effect of vitamin E and aspirin on the uterine artery blood flow in women with recurrent abortion: A single-blind randomized controlled trial.

P2860

Q35956397-B4A87A10-F300-485A-B576-B447C49CF891 Q49366131-6A94B8F3-9ADA-4E3E-A43C-9CE1E3A47EDD

P2860

Low dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage.

http://www.wikidata.org/entity/Q37479967

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 09 January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Low dose aspirin and low-molec ...... en with recurrent miscarriage.

@en

Low dose aspirin and low-molec ...... en with recurrent miscarriage.

@nl

type

label

Low dose aspirin and low-molec ...... en with recurrent miscarriage.

@en

Low dose aspirin and low-molec ...... en with recurrent miscarriage.

@nl

prefLabel

Low dose aspirin and low-molec ...... en with recurrent miscarriage.

@en

Low dose aspirin and low-molec ...... en with recurrent miscarriage.

@nl

P1433

Q37479967-A8AA8BF7-40A3-4257-8799-41F8D3D71DBA

P1476

Q37479967-B58CA11D-3B8A-415F-8CC2-1237D7650D5F

P2093

Q37479967-1E35A135-0336-4482-8CA5-ED724FD53B46

Q37479967-20779C04-FB4E-4D14-B214-BD85F7025C8D

Q37479967-2C497120-91DF-402E-AB9C-F2FB8C6C5C4F

Q37479967-9D271D63-B7B6-45CA-895F-8811D27B9711

P2860

Q37479967-02A470D5-0534-4D0E-85B0-F2BF3BAECD7F

Q37479967-02C0CAFD-DDD6-4D57-ABBC-0078F504DCC9

Q37479967-0BACCBBD-4DC5-47A0-AC1B-8EF5BDB99A06

Q37479967-0DE40E97-41CF-4A6E-AC82-49CB3C2172ED

Q37479967-1432D5CA-2D17-4854-8719-B45FDDAEAFF3

Q37479967-224174A4-D4CE-4AAF-869E-ED4B36E707B0

Q37479967-29CD72D3-52EB-4F3F-BEE1-1AB92941BB70

Q37479967-39A8D43F-BC42-4EDF-AB0C-ABDA9A1D56B3

Q37479967-3C4763DD-0AA2-4DF5-8015-6A49862EFB96

Q37479967-54CB3F89-A06D-4A6E-9765-F7CFDBCBBE65

P2888

Q37479967-1AA792AE-5A55-421E-8D40-ACA49DFB8019

P304

Q37479967-D1F7B090-9223-4D0D-BE6E-0621EF277634

P31

Q37479967-C5EBADC0-6C59-4BA7-B041-3F3BAEDA3EBC

P356

Q37479967-2259201C-190A-4D6C-A054-290AFE6C7396

P478

Q37479967-56A5AD11-1FFF-466C-B95C-6F605249C536

P50

Q37479967-C8AB1665-6DC9-4FAE-9DAF-B143F4780AF6

P577

Q37479967-B6F3D575-E40B-4CA2-B021-31E1E127F93A

P5875

Q37479967-38D3E3D1-EEDE-49E9-B2B5-16BA00973B38

P6179

Q37479967-E17F676C-153C-48C3-8746-E3B9488DCFE4

P698

Q37479967-04885A90-A612-49BE-A953-C38CFE41531B

P921

Q37479967-1CEDD00B-62B2-4DD6-88B1-C8BC227096EB

Q37479967-5247CBA5-4837-487E-B873-4509991D2CBC

Q37479967-8768178E-FC89-42E3-AC8E-7607F6225FAB

Q37479967-C6B02CB6-9C6B-4E42-BBB9-2CAC14A1EAFD

P932

Q37479967-A3F85FEA-E029-4F1B-84B3-9956617655E3

P356

P1433

BMC Research Notes

P1476

Low dose aspirin and low-molec ...... en with recurrent miscarriage.

@en

P2093

Aisha M Elbareg

http://www.w3.org/2001/XMLSchema#string

Bashur M Ashur

http://www.w3.org/2001/XMLSchema#string

Fathi M Essadi

http://www.w3.org/2001/XMLSchema#string

Mohamed O Elmahashi

http://www.w3.org/2001/XMLSchema#string

P2860

Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome

Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder

Low-dose aspirin for the prevention of atherothrombosis

Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment

Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study

Antenatal use of enoxaparin for prevention and treatment of thromboembolism in pregnancy.

Low molecular weight heparins: a guide to their optimum use in pregnancy.

Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy.

Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome.

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.

P2888

P304

23

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1756-0500-7-23

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-01-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259650832

http://www.w3.org/2001/XMLSchema#string

P6179

1003289771

http://www.w3.org/2001/XMLSchema#string

P698

24405979

http://www.w3.org/2001/XMLSchema#string

P921

P932

3892062

http://www.w3.org/2001/XMLSchema#string